Screener
Moderna MRNA Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 23.4%-29.1pp | 22.1%-32.0pp | 55.3%+0.6pp | 48.3%-19.2pp | 52.5%+19.5pp | |
| Operating margin | -149%-42.7pp | -153.3%-36.0pp | -158.1%-36.2pp | -155.2%-102pp | -106.3%-14.4pp | |
| Net margin | -141.4%-47.1pp | -143.6%-37.9pp | -145.2%-35.1pp | -139.6%-91.6pp | -94.3%+26.2pp | |
| Returns | ||||||
| Return on equity | -39%-11.5pp | -36.6%-7.2pp | -28.9%-0.1pp | -29.3%-10.1pp | -27.5%+15.0pp | |
| Return on invested capital | -43.8%-10.0pp | -42.5%-7.4pp | -35.9%+0.1pp | -33.6%-10.9pp | -33.8%+3.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×0.0× | 0.1×-0.1× | 0.2×-0.1× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.3×-1.6× | 2.4×-1.8× | 3.3×-0.4× | 3.9×-0.5× | 3.9×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×+0.1× | 0.2×+0.1× | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $16.99-29.9% | $18.75-28.1% | $22.24-21.7% | $23.92-20.0% | $24.22-20.6% | |
| Valuation | ||||||
| Market capitalization | $21.75B+102% | $20.15B+83.8% | $11.52B-28.0% | $10.05B-60.9% | $10.36B-77.2% | |
| Price / sales | 9.8×+6.3× | 9.1×+5.6× | 5.9×+1.0× | 4.5×-0.6× | 3.4×-5.6× | |
| Price / book | 3.2×+2.1× | 2.7×+1.6× | 1.3×-0.1× | 1.1×-1.1× | 1.1×-2.8× |
FAQ
- What are Moderna's profit margins?
- Moderna (MRNA) runs a 23.4% gross margin and a -149.0% operating margin, with a -141.4% net margin.
- Where do Moderna's ratios come from?
- Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
